ArticleQuantitative imaging in medicine and surgery2025
Added prognostic value of histogram features from preoperative multi-modal diffusion MRI in predicting Ki-67 proliferation for adult-type diffuse gliomas.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06572592 (The Prognostic Value of Preoperative Multi-model Diffusion MRI in Predicting Ki-67 Proliferation for Adult-type Diffuse Gliomas), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Prognostic Value of Preoperative Multi-model Diffusion MRI in Predicting Ki-67 Proliferation for Adult-type Diffuse Gliomas
Who cites it
1 citing paper in PubMed.
- Circulating tumor cells as a recurrence risk marker in glioma: a retrospective study.Translational cancer research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ki-67 labelling index (LI), a critical marker of tumor proliferation, is vital for grading adult-type diffuse gliomas and predicting patient survival. However, its accurate assessment currently relies on invasive biopsy or surgical resection. This makes it challenging to non-invasively predict Ki-67 LI and subsequent prognosis. Therefore, this study aimed to investigate whether histogram analysis of multi-parametric diffusion model metrics-specifically diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), and neurite orientation dispersion and density imaging (NODDI)-could help predict Ki-67 LI in adult-type diffuse gliomas and further predict patient survival. Methods: A total of 123 patients with diffuse gliomas who underwent preoperative bipolar spin-echo diffusion magnetic resonance imaging (MRI) were included. Diffusion metrics (DTI, DKI and NODDI) and their histogram features were extracted and used to develop a nomogram model in the training set (n=86), and the performance was verified in the test set (n=37). Area under the receiver operating characteristics curve of the nomogram model was calculated. The outcome cohort, including 123 patients, was used to evaluate the predictive value of the diffusion nomogram model for overall survival (OS). Cox proportion regression was performed to predict OS. Results: Among 123 patients, 87 exhibited high Ki-67 LI (Ki-67 LI >5%). The patients had a mean age of 46.08±13.24 years, with 39 being female. Tumor grading showed 46 cases of grade 2, 21 cases of grade 3, and 56 cases of grade 4. The nomogram model included eight histogram features from diffusion MRI and showed good performance for prediction Ki-67 LI, with area under the receiver operating characteristic curves (AUCs) of 0.92 [95% confidence interval (CI): 0.85-0.98, sensitivity =0.85, specificity =0.84] and 0.84 (95% CI: 0.64-0.98, sensitivity =0.77, specificity =0.73) in the training set and test set, respectively. Further nomogram incorporating these variables showed good discrimination in Ki-67 LI predicting and glioma grading. A low nomogram model score relative to the median value in the outcomes cohort was independently associated with OS (P<0.01). Conclusions: Accurate prediction of the Ki-67 LI in adult-type diffuse glioma patients was achieved by using multi-modal diffusion MRI histogram radiomics model, which also reliably and accurately determined survival. Trial Registration: ClinicalTrials.gov Identifier: NCT06572592.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.